Notable Mergers and Acquisitions of the Day 9/16: DSCP, BCS/LEH, PRGO
More News related to BCS
- Notable Analyst Rating Changes 6/29: DFS, LYG, TRW, BCS, JCP Upgraded; AA, SNY, BIIB, WW Downgraded
- Goldman Sachs Upgrades Lloyds Banking Group (LYG) to Conviction Buy
- Societe Generale Upgrades Barclays (BCS) to Hold
- Barclays (BCS) Accepts BlackRock (BLK) Offer to Acquire BGI
- Wealthy Investors Sit on Sidelines over Further Price Decline Concerns, Barclays Wealth Survey Says
More News related to DSCP
- S&P Announces Changes to US Indices: HEW for PSD, DSCP for NEOG
- Notable Mergers and Acquisitions of the Day 1/7: SAY, DSCP, GSK/GNLB
- Getinge Extends $53/Share Offer for Datascope (DSCP) Until Jan. 13
- Datascope (DSCP) to Sell EVH Product Line to Sorin Group
- Datascope (DSCP) Misses Q1 EPS by 3c, Guides Below for Q2
More News related to LEH
- Einhorn's Greenlight Gets Very-Long Gold (GLD, GDX), Also Likes Solar (JASO, WFR) and Other Energy (AYE, PCX, PTEN)
- Top 15 For 2008 (No. 3): Bank Runs
- Top 15 For 2008 (No. 14): M&A Wreckage
- Barclays (BCS) To Raise $9.7B In Capital From Middle East Investors
- Citadel Has Billions In Credit, Tries To Reassure Investors
- Getinge AB has agreed to acquire Datascope Corp. (NASDAQ: DSCP) for $53.00 per share, or an aggregate equity value of $865 million in cash.
The Board of Directors of Datascope has unanimously approved the transaction and will recommend the offer to Datascope's shareholders.
- Barclays (NYSE: BCS) confirms that it is discussing with Lehman Brothers (NYSE: LEH) the possible acquisition of certain Lehman Brothers assets on terms that would be attractive to Barclays shareholders.
Barclays said there can be no assurance that the discussions will result in an agreement. A further announcement will be made in due course.
Yesterday, Lehman Brothers filed chapter 11 bankruptcy after failing to find a buyer, or receiving a government bailout, over the weekend.
- Perrigo Company (Nasdaq: PRGO) announced today that it has acquired JB Laboratories for approximately $44 million in cash.
Based in Holland, Michigan, privately-held JB Laboratories is a contract manufacturer of OTC and nutrition products for leading healthcare suppliers in the U.S. The acquisition is expected to add more than $70 million of annual sales.
Related Categories
Special ReportsStocks Mentioned
+9.59
-0.39Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
